610 related articles for article (PubMed ID: 32513672)
1. Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
Drapkin BJ; Rudin CM
Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 32513672
[TBL] [Abstract][Full Text] [Related]
2. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
Ogino A; Choi J; Lin M; Wilkens MK; Calles A; Xu M; Adeni AE; Chambers ES; Capelletti M; Butaney M; Gray NS; Gokhale PC; Palakurthi S; Kirschmeier P; Oxnard GR; Sholl LM; Jänne PA
Mol Oncol; 2021 Jan; 15(1):27-42. PubMed ID: 32191822
[TBL] [Abstract][Full Text] [Related]
3. MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
Chalishazar MD; Wait SJ; Huang F; Ireland AS; Mukhopadhyay A; Lee Y; Schuman SS; Guthrie MR; Berrett KC; Vahrenkamp JM; Hu Z; Kudla M; Modzelewska K; Wang G; Ingolia NT; Gertz J; Lum DH; Cosulich SC; Bomalaski JS; DeBerardinis RJ; Oliver TG
Clin Cancer Res; 2019 Aug; 25(16):5107-5121. PubMed ID: 31164374
[TBL] [Abstract][Full Text] [Related]
4. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
5. Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.
Lochmann TL; Floros KV; Naseri M; Powell KM; Cook W; March RJ; Stein GT; Greninger P; Maves YK; Saunders LR; Dylla SJ; Costa C; Boikos SA; Leverson JD; Souers AJ; Krystal GW; Harada H; Benes CH; Faber AC
Clin Cancer Res; 2018 Jan; 24(2):360-369. PubMed ID: 29118061
[No Abstract] [Full Text] [Related]
6. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.
McFadden DG; Papagiannakopoulos T; Taylor-Weiner A; Stewart C; Carter SL; Cibulskis K; Bhutkar A; McKenna A; Dooley A; Vernon A; Sougnez C; Malstrom S; Heimann M; Park J; Chen F; Farago AF; Dayton T; Shefler E; Gabriel S; Getz G; Jacks T
Cell; 2014 Mar; 156(6):1298-1311. PubMed ID: 24630729
[TBL] [Abstract][Full Text] [Related]
7. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Rudin CM; Poirier JT; Byers LA; Dive C; Dowlati A; George J; Heymach JV; Johnson JE; Lehman JM; MacPherson D; Massion PP; Minna JD; Oliver TG; Quaranta V; Sage J; Thomas RK; Vakoc CR; Gazdar AF
Nat Rev Cancer; 2019 May; 19(5):289-297. PubMed ID: 30926931
[TBL] [Abstract][Full Text] [Related]
8. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
[No Abstract] [Full Text] [Related]
9. Unravelling the biology of SCLC: implications for therapy.
Sabari JK; Lok BH; Laird JH; Poirier JT; Rudin CM
Nat Rev Clin Oncol; 2017 Sep; 14(9):549-561. PubMed ID: 28534531
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Chemotherapy Resistance in SCLC.
Herzog BH; Devarakonda S; Govindan R
J Thorac Oncol; 2021 Dec; 16(12):2002-2015. PubMed ID: 34358725
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
14. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova EA; Nagel R; Berns A
Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
[TBL] [Abstract][Full Text] [Related]
15. [Research Advances on Transformation to Small Cell Lung Cancer].
Zhang S; Li S; Cui Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2021 Oct; 24(10):729-733. PubMed ID: 34696545
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
Xiong J; Barayan R; Louie AV; Lok BH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):521-542. PubMed ID: 35917883
[TBL] [Abstract][Full Text] [Related]
17. NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model.
Liu Y; Li Y; Liu S; Adeegbe DO; Christensen CL; Quinn MM; Dries R; Han S; Buczkowski K; Wang X; Chen T; Gao P; Zhang H; Li F; Hammerman PS; Bradner JE; Quayle SN; Wong KK
Cancer Res; 2018 Jul; 78(13):3709-3717. PubMed ID: 29760044
[TBL] [Abstract][Full Text] [Related]
18. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
[TBL] [Abstract][Full Text] [Related]
19. Small cell lung cancer: will recent progress lead to improved outcomes?
Pietanza MC; Byers LA; Minna JD; Rudin CM
Clin Cancer Res; 2015 May; 21(10):2244-55. PubMed ID: 25979931
[TBL] [Abstract][Full Text] [Related]
20. Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Hayashi R; Inomata M
Respir Investig; 2022 Mar; 60(2):197-204. PubMed ID: 34896039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
